3 minute read
Systems to help you meet global traceability requirements
Pharmaceutical production and packaging processes are continuously revised to ensure the best possible practices are maintained. Although these controls are in operation at different levels throughout the world, the goal remains the same – to deter counterfeiting and protect the end-user or patient.
Medicinal products must conform to regional and international practices such as product and packaging inspection. They also need to be identifiable from the point of production to the point of dispensing. These are only the basic global requirements. By implementing more advanced controls in the form of inspection, track and trace, and smart data management, manufacturers are preparing for international compliance and therefore can anticipate production growth.
In Europe alone, around $70 billion in revenue is lost annually and one in 10 pharmaceutical drugs or medicines sold in developing countries are either fake or sub-standard. Packaging and product controls have been challenged due to the level of production processes. Although global regulatory compliance is in force to protect end users from falsified medicines entering the supply chain, counterfeiters are continuously advancing their methods to sustain production. Not only is this illegal, counterfeit products can also be life threatening if administered.
SYSTEMS TO ENSURE SAFE PRODUCTS
The inspection systems from TracePack have been designed to operate with high volume product influx to ensure that every single saleable unit has been thoroughly checked, approved and released into the supply chain in an immaculate, safe state. The systems also ensure serialisation and aggregation for the complete control of your supply chain, helping to fight counterfeiting and guarantee higher product traceability.
The company’s wide selection of fully customisable inspection solutions for pharma can guarantee the consistent quality of your product. Its accurate detection technologies optimise efficiency by ensuring genuine reliability of all packaging and production processes, for guaranteed end-user safety within the pharmaceutical industry.
Expiring patents, low price generics, high R&D costs and narrowing margins make improved process efficiency and profitability through Overall Equipment Effectiveness (OEE) improvements increasingly important in pharma manufacturing. The vision and inspection products from TracePack help with these three traditional OEE drivers:
1. material handling efficiency and flexibility
2. product quality and yield
3. package safety and integrity.
Did you know?
Your traceability practices produce a huge amount of data that can be utilised in a smart way. Take advantage of this disposable data and leverage your investments with smart data management solutions from TracePack, to ensure the best possible practices for future production.
BRAND PROTECTION AND COMPLIANCE
As you prepare for compliance with global traceability requirements and transition from batch to item level serialisation, it is important to keep in mind that compliance requires much more than simply reading a code on a label or part.
For mass serialisation to support traceability, it is first essential to verify code quality and validate that all the encoded data is accurate and correctly formatted.
In-Sight Track & Trace works with networked In-Sight vision systems to create a complete identification and data verification solution for serialised labels on pharmaceutical packaging.
TracePack offers the widest range of vision and identification products available from a single source to provide you with a solution for every application and budget – for blisters, cartons, trays, aluminium foils, leaflets, layouts and packaging artworks as well as for foreign check detection. The vision systems for pharmaceuticals guarantee and monitor the quality of single product units (pills, capsules, vials and ampoules) as well oversee complete inspection control of the finished packed product (bottles, cartons and tubes), by guaranteeing rejection of all non-conforming parts. •